发明名称 CRYSTALLINE (-)-6- CHLORO-4- CYCLOPROPYLETHYNYL- 4-TRIFLUOROMETHYL- 3,4-DIHYDRO- 2(1H)-QUINAZOLINONE
摘要 The potent reverse transcriptase inhibitor (-)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1H)-quinazolinone is produced in solvate and crystalline form. These forms are designated Forms 1 and 2, and are characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV).
申请公布号 WO0029390(A1) 申请公布日期 2000.05.25
申请号 WO1999US27354 申请日期 1999.11.18
申请人 DU PONT PHARMACEUTICALS COMPANY 发明人 RABEL, SHELLY, R.;PATEL, MONA;PARSONS, RODNEY, LAWRENCE, JR.
分类号 A61P31/18;C07D239/78;C07D239/80;(IPC1-7):C07D239/80;A61K31/505 主分类号 A61P31/18
代理机构 代理人
主权项
地址